SERDAR BOZYEL, Tümer Erdem GÜLER, TOLGA AKSU, Kazım Serhan ÖZCAN

Supraventriküler Taşikardilerin Tedavisinde Radyofrekans Katater Ablasyon Tedavisi: Tek Merkez Deneyimi

GİRİŞ ve AMAÇ: Cushing Hastalığının nüks oranı yüksektir; bu nedenle, nüksü öngören klinik özellikler, yüksek riskli hastaları belirlemek için tanımlanmalıdır. Bu faktörler hastalığın yönetimini ve izlem sıklığını etkileyebilir. Nüks etmiş CH (RD) ve uzun sürekli remisyon (SR) sağlanmış hastaların klinik özelliklerini karşılaştırarak hastalık nüksünü öngören klinik faktörleri belirlemeyi amaçladık YÖNTEM ve GEREÇLER: Cerrahi tedavi uygulanan 85 CH olan hasta retrospektif olarak değerlendirildi. Preoperatif tanı testleri ve postoperatif hastalık aktivitesi kaydedildi. Hipofiz tümör boyutu, invazyonu, p53 ve Ki-67 immünhistokimyasal boyama verileri ile postoperatif kortizol aksı geridönüş zamanı değerlendirildi. BULGULAR: Çalışmaya 16 RD ve 54 SR hastası alındı. Preoperatif ACTH düzeyleri RD grubunda daha yüksekti. RD hastalarında preoperatif adenom boyutu ve kavernöz sinüs invazyonu ile Ki-67 indeksi SR grubuna göre daha yüksekti. RD'li 11 hastada (% 69) hızlı kortizol aksı geridönüşü görülürken SR grubunda sadece 6 hastada (% 11) vardı. TARTIŞMA ve SONUÇ: Preoperatif ACTH yüksekliği, atmış tümör boyutu, kavernöz sinüs invazyonu ve yüksek Ki-67 indeksi, Cushing hastalığında nüksü öngörebilir faktörlerdir. Bununla birlikte, hızlı kortizol aksı geridönüşü de nüks ile ilişkili bulunmuştur.

Radiofrequency Catheter Ablation Therapy in The Treatment of Supraventricular Tachycardia: A Single Center Experience

INTRODUCTION: Cushing's Disease (CD) has high recurrence rate therefore clinical features predicting recurrence should be defined to discriminate patients with high risk. These factors can effect management and follow-up frequency. We aimed to compare the clinical features of the patients with recurrent CD (RD) and sustained remission (SR) in order to determine clinical factors that might predict disease recurrence. METHODS: Surgically treated 85 patients with CD were evaluated retrospectively. Preoperative diagnostic tests and postoperative disease activity were noted. Pituitary tumor size, invasiveness and features such as p53 and Ki-67 immunohistochemical staining data also postoperative cortisol axis recovery time were evaluated.. RESULTS: 16 RD and 54 SR patients were enrolled to the study. Preoperative ACTH but not cortisol levels were higher in RD group. RD patients had higher preoperative adenoma size and cavernous sinus invasion rate and Ki-67 index than SR group. Eleven (69%) patients with RD had early recovery time while 6 (11%) patients in SR group DISCUSSION and CONCLUSION: Higher preoperative ACTH levels, tumor size, cavernous sinus invasion and Ki-67 immunostaining would predict recurrence in CD. Additionally, rapid recovery of cortisol axis was found to be related with recurrence.

PDF

___

1. Link MS. Evaluation and initial treatment of supraventricular tachycardia. N Engl J Med 2012;367:1438-48.
2. Orejarena LA, Vidaillet H Jr, DeStefano F, et al. Paroxysmal supraventricular tachycardia in the general population. J Am CollCardiol 1998;31:150- 7.
radiofrequency catheter ablation in the management of cardiac arrhythmias. Am J Med1996;100:344-56.
4. Blomström-Lundqvist C, Scheinman MM et al; European Society of Cardiology Committee, NASPE-Heart Rhythm Society. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developedin collaboration with NASPE-Heart Rhythm Society. J Am CollCardiol 2003;42:1493-531. 5. ins H, el-Atassi R, Kalbfleisch SJ, Langberg JJ, Morady F. Effect of operator experience on outcome of radiofrequency catheter ablation of accessory pathways. Am J Cardiol 1993; 71: 1104-
5.
6. Spector P, Reynolds MR, Calkins H, Sondhi M, Xu Y, Martin A, etal. Meta-analysis of ablation of atrial flutter and supraventriculartachycardia. Am J Cardiol 2009;104:671-7.
7. Papez AL, Al-Ahdab M, Dick M 2nd, Fischbach PS. Transcathetercryotherapy for the treatment of supraventricular tachyarrhythmiasin children: a single center experience. J Interv Card Electrophysiol2006;15:191-6.
8. Vukajlovic D, Neskovic AN. Learning curve in performing radiofrequencyablation of accessory pathways in patients with Wolf-Parkinson-White syndrome. Med Pregl 2006; 59: 468-71.
9. Calkins H, el-Atassi R, Kalbfleisch SJ, Langberg JJ, Morady F. Effect of operator Özcan SK ve ark. Kocaeli Medical J. 2017; 6;3:54-58 58 experience on outcome of radiofrequency catheter ablation of accessory pathways. Am J Cardiol 1993; 71: 1104-5.
10. Chen SA, Tai CT. Ablation of atrioventricular accessory pathways: current technique-state of the art. Pacing Clin Electrophysiol. 2001 Dec;24:1795-809.
11. Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, Huang SK, Liem LB, Klein LS, Moser SA, Bloch DA, Gillette P, Prystowsky E. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation. 1999 Jan 19;99:262-70.
12. Langberg JJ, Calkins H, Kim YN, Sousa J, el-Atassi R, Leon A, Borganelli M, Kalbfleisch SJ, Morady F. Recurrence of conduction in accessory atrioventricular connections after initially successful radiofrequency catheter ablation. J Am Coll Cardiol. 1992 Jun;19:1588-92.